+91 9891296838 / 9811747774
ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for • Treatment of cutaneous manifestations in patients with cutaneous Tcell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies.
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of ZOLINZA (vorinostat) Capsules brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ZOLINZA (vorinostat) Capsules medicine cost price in India.
The order for ZOLINZA (vorinostat) Capsules will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Vorinostat is used to treat a certain type of cancer (CTCL-cutaneous T-cell lymphoma). It works by slowing or stopping the growth of cancer cells.
ZOLINZA® (vorinostat) Capsules Initial U.S. Approval: 2006
Generic Name: vorinostat
Capsules: 100 mg .
60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ZOLINZA (vorinostat) Capsules on prescription and Import License in Patient's Name only.
For overseas patients, ZOLINZA (vorinostat) Capsules can be made available in Send your enquiry to find ZOLINZA (vorinostat) Capsules in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For ZOLINZA (vorinostat) Capsules Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Triplet Combination With Vorinostat Shows High Response Rate in Frontline MCL
FDA Approves New Drug for Cutaneous T-Cell Lymphomas For More Details